Overview and Scope
Naloxone spray refers to a substance that binds to opioid receptors and inhibits or reverses the actions of other opioids. Giving naloxone quickly undoes the effects of opioid medications, returning breathing to normal. It may be given intravenously or through nasal spray. Naloxone comes as a solution (liquid) to spray into the nose and each naloxone nasal spray contains a single dose of naloxone and should be used only once.
Sizing and Forecast
The naloxone spray market size has grown exponentially in recent years. It will grow from $540.68 billion in 2023 to $668.6 billion in 2024 at a compound annual growth rate (CAGR) of 23.7%. The growth in the historic period can be attributed to increased prevalence of opioid overdose, rising cases of opioid drug abuse in developed countries, advancements in drug development, increasing awareness about the importance of naloxone spray, growing healthcare expenditure.
The naloxone spray market size is expected to see exponential growth in the next few years. It will grow to $1592.93 billion in 2028 at a compound annual growth rate (CAGR) of 24.2%. The growth in the forecast period can be attributed to supportive government initiatives for naloxone distribution, expansion of naloxone accessibility programs, rising prescription rates for opioid analgesics, ongoing concerns and efforts to combat opioid crisis. Major trends in the forecast period include adoption of intranasal naloxone formulations, development of user-friendly naloxone devices, integration of naloxone education in opioid prescribing practices, inclusion of naloxone in community-based harm reduction programs.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/naloxone-spray-global-market-report
Segmentation & Regional Insights
The naloxone spray market covered in this report is segmented –
1) By Dosage: 2 mg/Actuation, 4 mg/Actuation
2) By Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Other distribution channels
North America was the largest region in the naloxone spray market in 2023. The regions covered in the naloxone spray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5339&type=smp
Major Driver Impacting Market Growth
The increase in the prevalence of opioid overdoses is contributing to the growth of the naloxone spray market. Opioids include medicines such as morphine, fentanyl, and tramadol and are used for the treatment of pain. However, due to their pharmacological effects, their non-medical use, prolonged use, misuse, and use without medical supervision can lead to opioid dependence, cause breathing difficulties, or even lead to death or other health problems. For instance, in February 2021, according to a report published by the Centers for Disease Control and Prevention (CDC), opioids were involved in 49,860 overdose deaths (or 70.6% of all drug overdose deaths). As a part of emergency medical treatment, naloxone nasal spray is used to reverse the life-threatening effects of an opiate or opioid overdose. Therefore, the increasing prevalence of opioid overdoses drives the growth of the naloxone spray market.
Key Industry Players
Major companies operating in the naloxone spray market report are Emergent BioSolutions Inc., Amphastar Pharmaceuticals Inc., Hikma Pharmaceuticals plc, Indivior plc, Nasus Pharma LLC, Neon Laboratories Limited, Opiant Pharmaceuticals Inc., Pfizer Inc., Samarth Pharma Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Troikaa Pharmaceuticals Ltd., Adapt Pharma Inc., AmerisourceBergen Corporation, Cardinal Health Inc., CVS Health Corporation, Express Scripts Holding Company, Harm Reduction Coalition Inc., Kaleo Inc., McKesson Corporation, Mundipharma International Limited, Mylan N. V., NextDistro Inc., Rite Aid Corporation, Novartis International AG, Sandoz International GmbH, Fresenius Kabi USA LLC, Hospira Inc., West-Ward Pharmaceuticals Corp., Walgreens Boots Alliance Inc., Lupin Ltd.
The naloxone spray market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
